Neurological Genetics tests in Dubai & UAE

Compare available Neurological Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,000.00–3,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Neurological Genetics test prices

Showing 46–60 of 71 matching tests.

Neurological Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4763 L1CAM Gene MASA Syndrome Genetic Test This test evaluates the L1CAM gene for pathogenic variants associated with MASA syndrome.	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the L1CAM gene", "Copy number variants (CNVs) in the L1CAM gene"] Parameters [] Preparation [] Indications ["Clinical signs suggestive of MASA syndrome", "Family history of L1CAM-related disorders", "Carrier or presymptomatic testing in at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 81334-3 ICD-10: Q04.8 Clinical summary This test evaluates the L1CAM gene for pathogenic variants associated with MASA syndrome.
TEST-3809 MATR3 Gene Amyotrophic Lateral Sclerosis Type 21 (ALS21) Genetic Test This test evaluates the MATR3 gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis type 21 (ALS21).	Whole Blood (EDTA Tube) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MATR3 gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["Informed consent must be obtained prior to sample collection.", "Pre-test genetic counseling is strongly recommended."] Indications ["Clinical diagnosis of ALS with suspected autosomal dominant inheritance", "Family history suggestive of ALS21", "Asymptomatic adult relatives of a known mutation carrier"] Measurement technique Confirm with laboratory Codes LOINC: 94765-5 ICD-10: G12.21 Clinical summary This test evaluates the MATR3 gene for pathogenic variants associated with Amyotrophic Lateral Sclerosis type 21 (ALS21).
TEST-5616 MTPAP Gene Spastic Ataxia Type 4 (Autosomal Recessive) Genetic Test This test identifies pathogenic variants in the MTPAP gene associated with autosomal recessive spastic ataxia type 4 (SPAX4). It uses Next-Generation Sequencing (NGS) for comprehen...	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MTPAP gene", "Coding region and splice site variants"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected diagnosis of autosomal recessive spastic ataxia type 4 (SPAX4)", "Family history of SPAX4", "Carrier screening for at-risk relatives"] Measurement technique Confirm with laboratory Codes LOINC: 21636-8 ICD-10: G11.9 Clinical summary This test identifies pathogenic variants in the MTPAP gene associated with autosomal recessive spastic ataxia type 4 (SPAX4). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-5278 MYOT Gene Myotilinopathy Genetic Test This test identifies pathogenic variants within the MYOT gene associated with myotilinopathy.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYOT gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number variations (CNVs)"] Parameters [] Preparation ["Provide a detailed clinical history", "Genetic counseling session required before sampling", "No fasting required"] Indications ["Clinical suspicion of myotilin-related myopathy (limb-girdle muscular dystrophy type 1A)", "Family history of myotilinopathy", "Need for definitive diagnosis to guide treatment and management"] Measurement technique Confirm with laboratory Codes LOINC: 91247-9 ICD-10: G71.0 Clinical summary This test identifies pathogenic variants within the MYOT gene associated with myotilinopathy.
TEST-4643 NDUFS8 Gene Leigh Syndrome Genetic Test This test analyzes the NDUFS8 gene to detect pathogenic variants associated with Leigh syndrome.	Whole blood (EDTA or ACD tube), buccal swab, dried blood spot (FTA card), or extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFS8 gene", "Coding regions and splice sites of the NDUFS8 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Suspected Leigh syndrome based on clinical presentation", "Family history of Leigh syndrome or related mitochondrial disorders", "Carrier screening for NDUFS8-related Leigh syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G31.82 Clinical summary This test analyzes the NDUFS8 gene to detect pathogenic variants associated with Leigh syndrome.
TEST-5226 NHLRC1 Gene Myoclonic Epilepsy of Lafora Genetic Test This test identifies pathogenic variants in the NHLRC1 gene, associated with Lafora progressive myoclonus epilepsy.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NHLRC1 gene", "Point mutations", "Small insertions/deletions", "Splice-site alterations"] Parameters [] Preparation ["Genetic counselling is mandatory pre-test for minors", "A pedigree chart of affected family members is required"] Indications ["Unexplained myoclonus and seizures in children aged 6–18", "Asymptomatic siblings of confirmed cases", "Suspected late-onset Lafora disease in adults"] Measurement technique Confirm with laboratory Codes LOINC: 91757-9 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the NHLRC1 gene, associated with Lafora progressive myoclonus epilepsy.
TEST-3901 NLGN4X Gene Autism Susceptibility, X‑linked Type 2 Genetic Test This genetic test detects pathogenic variants, including single nucleotide variants, small indels, and copy number changes, within the NLGN4X gene.	Peripheral Blood or Dried Blood Spot (FTA Card)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in NLGN4X gene", "Small indels in NLGN4X gene", "Copy number changes in NLGN4X gene"] Parameters [] Preparation ["No specific fasting required.", "Inform the phlebotomist of any medications being taken."] Indications ["Individuals with clinical features suggestive of X-linked autism spectrum disorder or intellectual disability.", "Family history of X-linked intellectual disability.", "Genetic counseling for families with affected members."] Measurement technique Confirm with laboratory Codes LOINC: 96393-4 ICD-10: F84.0, Z13.85, Z15.89 Clinical summary This genetic test detects pathogenic variants, including single nucleotide variants, small indels, and copy number changes, within the NLGN4X gene.
TEST-5436 PARK7 (PARK7) Gene Parkinson Disease Genetic Test This test identifies pathogenic variants in the PARK7 gene associated with autosomal recessive early-onset Parkinson disease.	Peripheral Whole Blood (EDTA) or Buccal Swab (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PARK7 gene", "Full coding region and splice sites"] Parameters [] Preparation ["No special preparation needed"] Indications ["Confirmation of diagnosis for early-onset Parkinson's disease", "Genetic predisposition assessment", "Family planning guidance"] Measurement technique Confirm with laboratory Codes LOINC: 94224-1 ICD-10: G20, Z15.89, Z82.79 Clinical summary This test identifies pathogenic variants in the PARK7 gene associated with autosomal recessive early-onset Parkinson disease.
TEST-4178 PCDH11X Gene Dyslexia Genetic Test This test evaluates the PCDH11X gene for variants associated with dyslexia susceptibility using next-generation sequencing.	Whole blood (EDTA), extracted DNA, or dried blood spot on FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PCDH11X gene variants", "Single-gene high-resolution variant detection"] Parameters [] Preparation ["Clinical history review", "Mandatory genetic counselling session"] Indications ["Suspected genetic predisposition to dyslexia", "Family history of dyslexia", "Need for molecular basis for personalized intervention"] Measurement technique Confirm with laboratory Codes LOINC: 94037-6 ICD-10: F81.0 Clinical summary This test evaluates the PCDH11X gene for variants associated with dyslexia susceptibility using next-generation sequencing.
TEST-5637 PLP1 Gene Sequencing for SPG2 via Next‑Generation Sequencing (NGS) Test This test identifies pathogenic variants in the PLP1 gene associated with Hereditary Spastic Paraplegia Type 2 (SPG2).	Peripheral whole blood (EDTA) or FTA card	3–4 weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PLP1 gene", "Coding exons and intron-exon boundaries of PLP1"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Suspected Hereditary Spastic Paraplegia Type 2 (SPG2)", "Family history of SPG2", "Progressive neurological symptoms suggestive of SPG2"] Measurement technique Confirm with laboratory Codes LOINC: 81265-0 ICD-10: G11.4 Clinical summary This test identifies pathogenic variants in the PLP1 gene associated with Hereditary Spastic Paraplegia Type 2 (SPG2).
TEST-5626 PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test This test identifies pathogenic variants in the PRICKLE1 gene associated with Progressive Myoclonus Epilepsy Type 1A.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRICKLE1 gene"] Parameters [] Preparation [] Indications ["Symptomatic individuals suspected of having Progressive Myoclonus Epilepsy Type 1A", "Pre-symptomatic individuals with a family history of PME1A", "Carrier identification in families with PME1A"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G40.3 Clinical summary This test identifies pathogenic variants in the PRICKLE1 gene associated with Progressive Myoclonus Epilepsy Type 1A.
TEST-5423 PRKN (PARK2) Gene Parkinson Disease Genetic Test This test evaluates the PRKN (PARK2) gene for pathogenic variants associated with early-onset Parkinson disease.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKN gene", "Copy Number Variants (CNVs) in the PRKN gene"] Parameters [] Preparation [] Indications ["Diagnosis of early-onset Parkinson disease", "Family risk assessment for Parkinson disease", "Clarification of prognosis"] Measurement technique Confirm with laboratory Codes LOINC: 82498-8 ICD-10: G20 Clinical summary This test evaluates the PRKN (PARK2) gene for pathogenic variants associated with early-onset Parkinson disease.
TEST-5480 PSEN1 Gene Pick Disease Genetic Test This test identifies pathogenic variants in the PSEN1 gene associated with Pick disease and frontotemporal dementia.	Whole Blood (EDTA) or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PSEN1 gene", "Coding exons and splice sites of the PSEN1 gene"] Parameters [] Preparation ["Fasting is not required", "No specific medication or diet restrictions"] Indications ["Individuals with clinical symptoms suggestive of Pick disease or FTD", "Family members of individuals diagnosed with PSEN1-related Pick disease", "Risk assessment for individuals with a family history of FTD"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G31.01 Clinical summary This test identifies pathogenic variants in the PSEN1 gene associated with Pick disease and frontotemporal dementia.
TEST-3852 RABGGTA Gene Autism Spectrum Disorder Genetic Test This test evaluates the RABGGTA gene for pathogenic variants linked to syndromic autism spectrum disorder using next-generation sequencing.	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RABGGTA gene", "Copy number variants (CNVs) in the RABGGTA gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications without consulting a physician", "Informed consent required before sample collection"] Indications ["Suspected syndromic autism spectrum disorder", "Family history of RABGGTA-related disorders", "Need for genetic confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 101420-0 ICD-10: F84.0 Clinical summary This test evaluates the RABGGTA gene for pathogenic variants linked to syndromic autism spectrum disorder using next-generation sequencing.
TEST-4495 RNF39 Gene Genetic Test (Hippocampal Long-Term Potentiation) This genetic test evaluates variants in the RNF39 gene associated with altered hippocampal long-term potentiation and neuroplasticity.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["RNF39 gene variants", "Hippocampal long-term potentiation (LTP)", "Neuroplasticity"] Parameters [] Preparation [] Indications ["Personalized strategies for neurological health", "Anti-aging interventions", "Cognitive performance optimization", "Early monitoring for neurodegenerative conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21752-8 ICD-10: Z13.89 Clinical summary This genetic test evaluates variants in the RNF39 gene associated with altered hippocampal long-term potentiation and neuroplasticity.

Category overview

Neurological Genetics: overview

Securing a deep, fundamental understanding of your family's neurological blueprint allows for proactive, highly informed medical decisions that protect your long-term cognitive and motor vitality. As the core of our advanced neuro-diagnostic laboratory services, the Neurological Genetics department utilizes state-of-the-art sequencing and targeted DNA analysis to uncover the precise genetic mutations driving rare brain, spinal cord, and peripheral nerve diseases. By leveraging advanced molecular technology, this expansive profiling helps establish an absolute diagnosis for elusive conditions, safely guiding your healthcare provider in tailoring highly personalized precision medicine, supportive therapies, and proactive family planning. Trusted for clinical rigor across premier diagnostic labs in the UAE, DNA Labs guarantees strict patient confidentiality, exceptional analytical accuracy, and incredibly prompt turnaround times. Take an empowered step toward targeted neurological support—schedule your neurological genetics testing in UAE, coordinate a seamless clinic or home sample collection, or connect with our specialized specialists.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.